PubMed Health⌕ Search

Biomedical subjects

J E Hansen

Publications and source records attributed to J E Hansen.

At least 163 records · Page 9Linked to original sources

The microheterogeneity of alpha 1-acid glycoprotein in inflammatory lung disease, cancer of the lung and normal health.

The concentration of alpha 1-acid glycoprotein (AGP, orosomucoid) was measured in sera from 19 patients with primary squamous cell carcinoma of the lung, 16 patients with an inflammatory lung disease and 17 persons with normal health. All sera were further subjected to crossed immuno-affinoelectrophoresis with addition of Con A in the first dimension and sugar in the second dimension. The distribution of AGP into four microheterogeneity forms, which were the result of this analysis, was estimated by measuring the area under the precipitation curve. The microheterogeneity patterns of AGP in the three groups were significantly different from each other (p less than 0.001). The total concentration of AGP in the two groups of patients was significantly different from the concentration in the healthy group (p less than 0.001).

Carcinoma, Squamous Cell↗

Exercise instruments, schemes, and protocols for evaluating the dyspneic patient.

A number of exercise instruments, schemes, and protocols for evaluating the dyspneic patient are characterized. The cycle is safe, allows quantification of external work and work efficiency, and has less measurement artifact, whereas the treadmill allows a higher maximum oxygen uptake. Repeated measures of cardiorespiratory function at rest, during several minutes of warmup, and during work, with equal 1-min increments, to a symptom-limited maximum in approximately 10 min is an advantageous protocol.

Dyspnea↗

Predicted values for clinical exercise testing.

Following thorough evaluation at rest, 265 of 400 current or ex-shipyard workers rode a cycle ergometer with equal work increments each minute to exhaustion while continuous multiple noninvasive cardiorespiratory measures and intermittent intra-arterial blood pressure and blood gas measures were made. Seventy-seven men, with a mean age of 54, including some who were smokers, obese, or hypertensive, were judged to have normal cardiorespiratory systems based on history, physical, electrocardiogram during rest and exercise, chest X-ray, pulmonary function tests, and exercise performance. Their responses to exercise are given. It was unusual to find at maximal exercise a breathing reserve less than 11 L/min, arterial PO2 less than 80 mm Hg, alveolar-arterial PO2 difference greater than 38 mm Hg, arterial-end tidal PCO2 difference greater than 1 mm Hg, respiratory frequency greater than 60, or a dead space/tidal volume ratio greater than 0.28. The normal anaerobic threshold/maximal O2 uptake ratio exceeded 40%. With maximal exercise, the intra-arterial systolic and diastolic pressures rose an average of 68 and 13 mm Hg, respectively. For predicting maximal oxygen uptake and oxygen pulse in an overweight man, we find it preferable to use age and height rather than age and weight.

Adult↗

Normal values in adults during exercise testing.

The cardiopulmonary response to 1-minute incremental cycle exercise in a population of 77 sedentary middle-aged men provides an opportunity to develop typical values that may prove useful in assessing impairment and disease. Maximal oxygen uptake can be predicted from age and height, using standard predicting formulas. Patterns of change in ventilation, anaerobic threshold, heart rate, oxygen pulse, and arterial blood gases during exercise are similar to those previously reported, although the magnitude of changes may be different.

Body Weight↗

Exercise gas exchange in asthmatics after beta-adrenergic blockade.

Pharmacologic beta-adrenergic blockade reduces maximal heart rate (HR) during exercise but variable results have been reported for minute ventilation (VE), CO2 output (VCO2), and O2 uptake (VO2). A total group of 19 subjects with mild asthma was studied. We studied 16 subjects from the group who received placebo or pindolol, a beta-adrenergic antagonist, during 1-min incremental exercise on a cycle ergometer. During incremental exercise, HR, VE, VCO2, and VO2 were less after beta-blockade than after placebo at the same work rate below the anaerobic threshold. Maximal HR, VE, VO2, VCO2, and work rate were significantly less after beta-blockade. In addition, we studied six subjects from the group, including three who had also performed incremental exercise, during the steady state of constant-work cycling exercise. We found no difference in VE, VCO2, or VO2 although HR was less after beta-blockade. We conclude that beta-adrenergic blockade affects gas exchange by delaying the normal cardiovascular response to exercise. Decreased VE during incremental exercise is due to slowed delivery of CO2 load to the lungs rather than alterations in substrate, lung function, or ventilatory control.

Adolescent↗

Optimizing the exercise protocol for cardiopulmonary assessment.

Twelve normal men performed 1-min incremental exercise tests to exhaustion in approximately 10 min on both treadmill and cycle ergometer. The maximal O2 uptake (VO2 max) and anaerobic threshold (AT) were higher (6 and 13%, respectively) on the treadmill than the cycle; the AT was reached at about 50% of VO2 max on both ergometers. Maximal CO2 output, heart rate, and O2 pulse were also slightly, but significantly higher on the treadmill. Maximal ventilation, gas exchange ratio, and ventilatory equivalents for O2 and CO2 for both forms of exercise were not significantly different. To determine the optimum exercise test for both treadmill and cycle, we exercised five of the subjects at various work rate increments on both ergometers in a randomized design. The treadmill increments were 0.8, 1.7, 2.5, and 4.2%/min at a constant speed of 3.4 mph, and 1.7 and 4.2%/min at 4.5 mph. Cycle increments were 15, 30, and 60 W/min. The VO2 max was significantly higher on tests where the increment magnitude was large enough to induce test durations of 8-17 min, but the AT was independent of test duration. Thus, for evaluating cardiopulmonary function with incremental exercise testing by either treadmill or cycle, we suggest selecting a work rate increment to bring the subject to the limit of his tolerance in about 10 min.

Adult↗

Effects of obesity on respiratory function.

Obesity, because it alters the relationship between the lungs, chest wall, and diaphragm, has been expected to alter respiratory function. We studied 43 massively obese but otherwise normal, nonsmoking, young adults with spirometry, lung volume measurement by nitrogen washout, and single-breath diffusing capacity for carbon monoxide (DLCO). Changes in respiratory function were of two types, those that changed in proportion to degree of obesity--expiratory reserve volume (ERV) and DLCO--and those that changed only with extreme obesity--vital capacity, total lung capacity, and maximal voluntary ventilation. When compared with commonly used predicting equations, we found that mean values of subjects grouped by degree of obesity were very close to predicted values, except in those with extreme obesity in whom weight (kg)/height (cm) exceeded 1.0. In 29 subjects who lost a mean of 56 kg, significant increases in vital capacity, ERV, and maximal voluntary ventilation were found, along with a significant decrease in DLCO. Because most subjects fell within the generally accepted 95% confidence limits for the predicted values, we concluded that obesity does not usually preclude use of usual predictors. An abnormal pulmonary function test value should be considered as caused by intrinsic lung disease and not by obesity, except in those with extreme obesity.

Adult↗

A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus.

Twenty-five consecutive patients admitted with status asthmaticus were blindly randomized to receive intravenous (IV) methylprednisolone every six hours for three days at one of the following dosages: (1) low, 15 mg; (2) medium, 40 mg; or (3) high, 125 mg. All other therapy, including IV and inhaled bronchodilators, was kept constant. We measured forced expiratory volume in 1 s (FEV1) to quantitate response. The high-dose group improved significantly by the end of the first day, the medium-dose group improved by the middle of the second day, but the low-dose group did not improve significantly in three days. Together, the high- and medium-dose groups were significantly improved (FEV1 greater than 50% of predicted) compared with the low-dose group. No serious steroid side effects were encountered. We conclude that the greater benefit of higher doses of steroids, such as 125 mg of methylprednisolone every six hours, justifies their use in severe asthma.

Adult↗

Effect of variations in room temperature on measured values of blood gas quality-control materials.

We compared four commercial quality-control materials equilibrated in sealed ampoules at 21 or 26 degrees C in three models of blood gas machines and found po2 differences of about 13.3 Pa (10 mmHg) for an aqueous mixture with hemoglobin; about 6.7 Pa (5 mmHg) for two aqueous buffers without hemoglobin, and none for a fluorocarbon-containing emulsion. Differences for pco2 and pH were small but statistically significant. Variability within machines for pco2, po2, and pH was small but differences among machines were large, especially for po2. These results emphasize that aqueous solutions and hemoglobin-containing mixtures used for proficiency testing and quality control should be equilibrated at the temperature recommended by the manufacturer, opened, and sampled promptly.

Blood Gas Analysis↗

The value of exercise in testing beta blockade and airway reactivity in asthmatic patients.

On separate days, in double-blind fashion, 23 subjects with mild or moderate asthma were injected intravenously with a placebo or 0.4 mg pindolol. Plethysmographic and spirometric measurements were performed before and after injection and repeatedly after exhausting incremental bicycle ergometer exercise. The mean reduction in maximal exercise heart rate of 26 bpm after pindolol compared to placebo confirmed significant cardiovascular beta blockade. Baseline 1-second vital capacity (FEV1) values and other flow rates were similar in both trials. There were similar reductions in FEV1 (median of 1% to 2% and mean of 3% to 5%) and other flow rates immediately after injection of placebo or pindolol. Exercise-induced bronchospasm (EIB) occurred in 34 of 46 trials and tended to be more severe in subjects with more baseline airway obstruction. Minimal EIB (FEV1 to 80% to 90% of baseline values) developed in eight after taking placebo and in seven after taking pindolol; mild EIB (FEV1 to 60% to 79% of baseline) developed in the five after placebo and six after pindolol and moderate EIB (FEV1 to 40% to 59% of baseline) developed in three after placebo and five after pindolol. In five subjects, FEV1 was reduced to a greater extent after placebo than after pindolol (median of 6%), whereas in 13 subjects, FEV1 was reduced to a greater extent after pindolol than after placebo (median of 10%). These small differences in FEV1 between placebo and pindolol were significant by the t test after exercise but not before exercise. Thus, exercise appears to increase the sensitivity in evaluating airway reactivity in asthmatic patients and also tests the effectiveness of cardiovascular beta blockade.

Adolescent↗

Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction.

The influence of chronic obstructive pulmonary disease (COPD) on exercise ventilatory and gas exchange kinetics was assessed in nine patients with stable airway obstruction (forced expired volume at 1 s = 1.1 +/- 0.33 liters) and compared with that in six normal men. Minute ventilation (VE), CO2 output (VCO2), and O2 uptake (VO2) were determined breath-by-breath at rest and after the onset of constant-load subanaerobic threshold exercise. The initial increase in VE, VCO2, and VO2 from rest (phase I), the subsequent slow exponential rise (phase II), and the steady-state (phase III) responses were analyzed. The COPD group had a significantly smaller phase I increase in VE (3.4 +/- 0.89 vs. 6.8 +/- 1.05 liters/min), VCO2 (0.10 +/- 0.03 vs. 0.22 +/- 0.03 liters/min), VO2 (0.10 +/- 0.03 vs. 0.24 +/- 0.04 liters/min), heart rate (HR) (6 +/- 0.9 vs. 16 +/- 1.4 beats/min), and O2 pulse (0.93 +/- 0.21 vs. 2.2 +/- 0.45 ml/beat) than the controls. Phase I increase in VE was significantly correlated with phase I increase in VO2 (r = 0.88) and HR (r = 0.78) in the COPD group. Most patients also had markedly slower phase II kinetics, i.e., longer time constants (tau) for VE (87 +/- 7 vs. 65 +/- 2 s), VCO2 (79 +/- 6 vs. 63 +/- 3 s), and VO2 (56 +/- 5 vs. 39 +/- 2 s) and longer half times for HR (68 +/- 9 vs. 32 +/- 2 s) and O2 pulse (42 +/- 3 vs. 31 +/- 2 s) compared with controls. However, tau VO2/tau VE and tau VCO2/tau VE were similar in both groups. The significant correlations of the phase I VE increase with HR and VO2 are consistent with the concept that the immediate exercise hyperpnea has a cardiodynamic basis. The slow ventilatory kinetics during phase II in the COPD group appeared to be more closely related to a slowed cardiovascular response rather than to any index of respiratory function. O2 breathing did not affect the phase I increase in VE but did slow phase II kinetics in most subjects. This confirms that the role attributed to the carotid bodies in ventilatory control during exercise in normal subjects also operates in patients with COPD.

Carbon Dioxide↗

Evaluation of blood gas quality control and proficiency testing materials by tonometry.

Because of consistent differences found by other investigators and by us, we systematically tonometered, sampled, and measured PO2 and PCO2 concentrations of fresh blood, plasma, and several commercial quality control materials in three models of semiautomated blood gas machines. We found no significant differences between materials or machines for PCO2 between 25 to 72 mm Hg. For tonometered PO2 of approximately 25 to 100 mm Hg, the measured PO2 concentrations were accurate for blood, high for materials with hemoglobin or fluorocarbon (high O2 capacity), and very high for other materials (low O2 capacity). A low O2 capacity material tonometered to a PO2 of 0 mm Hg gave very high values in semiautomated machines and gave correct values only when injected repeatedly without interrupting rinse cycles into a manual machine. These findings indicate significant contamination of blood gas machines with fluids other than the sample so that low O2 capacity quality control materials are inadequate for proficiency testing at degrees of PO2 below 100 mm Hg.

Blood Gas Analysis↗

Comparison of physiologic dead space/tidal volume ratio and alveolar-arterial PO2 difference during incremental and constant work exercise.

We prefer 1-min incremental exercise testing on a cycle ergometer rather than constant work studies because of its speed, repeatability, and ease of identification of the anaerobic threshold. Although values such as VO2 and anaerobic threshold from both types of studies are reported to be comparable, we questioned whether VD/VT and AaPO2, which depend on simultaneous arterial blood and mixed expired gas sampling, would also be reliable during incremental testing. In 23 patients we did both a constant work test at below the anaerobic threshold and a 1-min incremental test. At matched VO2 we found no difference between VD/VT and AaPO2 despite anticipated differences in VE, VCO2, and R because of differences in their rates of increase. We conclude that VD/VT and AaPO2, determined during 1-min incremental exercise tests, are equivalent to those from constant work tests and that a separate constant work study is not needed for these measurements if determined below the anaerobic threshold.

Adult↗

Myxoedema and Raynaud's phenomenon.

Cold hands is a common complaint in myxoedema and were reported by 15 of 17 patients before treatment of myxoedema with 4 having Raynaud's phenomenon. An increased cold sensitivity of the digital arteries could be demonstrated during finger cooling in about half of the patients and Raynaud's phenomenon was verified in the 4 patients as digital arterial closure. The cold sensitivity decreased significantly after treatment with L-thyroxine. The increased cold sensitivity in untreated myxoedema is probably due to an increased sympathetic discharge to the hands that might disclose a predisposition for Raynaud's phenomenon.

Adult↗